Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Lancet Diabetes Endocrinol ; 9(9): 606-621, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-34242583

RESUMO

Osteoporotic or fragility fractures affect one in two women and one in five men who are older than 50. These events are associated with substantial morbidity, increased mortality, and an impaired quality of life. Recommended general measures for fragility fracture prevention include a balanced diet with an optimal protein and calcium intake and vitamin D sufficiency, together with regular weight-bearing physical exercise. In this narrative Review, we discuss the role of nutrients, foods, and dietary patterns in maintaining bone health. Much of this information comes from observational studies. Bone mineral density, microstructure-estimated bone strength, and trabecular and cortical microstructure are positively associated with total protein intake. Several studies indicate that fracture risk might be lower with a higher dietary protein intake, provided that the calcium supply is sufficient. Dairy products are a valuable source of these two nutrients. Hip fracture risk appears to be lower in consumers of dairy products, particularly fermented dairy products. Consuming less than five servings per day of fruit and vegetables is associated with a higher hip fracture risk. Adherence to a Mediterranean diet or to a prudent diet is associated with a lower fracture risk. These various nutrients and dietary patterns influence gut microbiota composition or function, or both. The conclusions of this Review emphasise the importance of a balanced diet including minerals, protein, and fruit and vegetables for bone health and in the prevention of fragility fractures.


Assuntos
Suplementos Nutricionais , Estado Nutricional , Osteoporose/prevenção & controle , Fraturas por Osteoporose/prevenção & controle , Cálcio da Dieta/administração & dosagem , Ingestão de Alimentos , Feminino , Humanos , Osteoporose/dietoterapia , Fraturas por Osteoporose/dietoterapia
2.
Clin Interv Aging ; 14: 1693-1703, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31631990

RESUMO

PURPOSE: Define the effectiveness of teriparatide (TPTD) treatment on reducing the incidence of new vertebral compression fractures (NVCFs) and back pain and improving quality of life after percutaneous kyphoplasty (PKP). METHODS: Two years of clinical follow-up data from primary osteoporotic women who had experienced initial osteoporotic vertebral compression fractures (OVCFs) and received PKP plus 12-month TPTD (n=113) or basic treatment (BT) of calcium and vitamin D supplements (n=208) were retrospectively collected. The risk of NVCFs over each 6-month period in the TPTD group was evaluated and compared with the BT group using a logistic regression. Health-related quality of life (HRQoL, EQ-5D questionnaire), back pain [100 mm visual analog scale (VAS)] and bone mineral density (BMD) of the spine were analyzed using linear mixed models for repeated measures (LMMRM). RESULTS: Logistic regression analysis adjusting for baseline characteristics showed that patients in the TPTD group had a lower risk of NVCFs compared with those receiving BT during the final three observation intervals (6-12 months, OR=0.189, 95% CI=0.030-0.681, p=0.046; 12-18 months, OR=0.009, 95% CI=0.0001-0.111, p=0.001; 18-24 months, OR=0.024, 95% CI=0.0009-0.264, p=0.009, respectively). Significant improvements in adjusted EQ-5D and back pain VAS scores were identified in the TPTD group compared with the BT group, and this improvement was sustained for at least 12 months after teriparatide treatment was discontinued (both p<0.001). The BMD of the spine also showed a higher T-value in the TPTD group compared with the BT group (p<0.001). CONCLUSION: In routine clinical practice, for patients with OVCFs who receive the PKP procedure, TPTD treatment may be a preferable subsequent therapy because of its ability to reduce the incidence of NVCFs and sustain a high quality of life and back pain alleviation.


Assuntos
Conservadores da Densidade Óssea/uso terapêutico , Fraturas por Compressão/tratamento farmacológico , Cifoplastia/métodos , Osteoporose Pós-Menopausa/tratamento farmacológico , Fraturas por Osteoporose/dietoterapia , Qualidade de Vida , Idoso , Idoso de 80 Anos ou mais , Feminino , Fraturas por Compressão/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Osteoporose Pós-Menopausa/cirurgia , Fraturas por Osteoporose/cirurgia , Estudos Retrospectivos , Teriparatida/uso terapêutico , Resultado do Tratamento
3.
Praxis (Bern 1994) ; 107(15): 817-824, 2018 Jul.
Artigo em Alemão | MEDLINE | ID: mdl-30043704

RESUMO

The Influence of Protein on the Prevention of Fragility Fractures Among Senior Adults Abstract. The aim of this review article is to discuss protein intake in senior adults at risk for fragility fractures as a modifiable factor for fracture prevention. Proteins are building blocks of the bone matrix and the muscles. This dual function fits in with the concept of prevention of fragility fractures in senior adults aimed at reducing both bone loss and falls. In older adults, a protein-rich diet could be another simple and effective way to promote bone and muscle health, in addition to the established recommendations for adequate vitamin D and calcium intake.


Assuntos
Doenças Ósseas Metabólicas/prevenção & controle , Dieta Rica em Proteínas , Idoso Fragilizado , Fraturas por Osteoporose/prevenção & controle , Deficiência de Proteína/prevenção & controle , Acidentes por Quedas/prevenção & controle , Idoso , Idoso de 80 Anos ou mais , Doenças Ósseas Metabólicas/dietoterapia , Cálcio da Dieta/administração & dosagem , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fraturas por Osteoporose/dietoterapia , Deficiência de Proteína/dietoterapia , Fatores de Risco , Sarcopenia/dietoterapia , Sarcopenia/prevenção & controle , Vitamina D/administração & dosagem
4.
Clin Nutr ; 37(1): 329-335, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-28143667

RESUMO

BACKGROUND & AIMS: The incidence of osteoporotic fractures is lower in countries in the Mediterranean basin. Virgin olive oil, a key component of the Mediterranean Diet (MDiet), with recognised beneficial effects on metabolism and cardiovascular health, may decrease the risk of osteoporotic fractures. The aim to this study was to explore the effect of chronic consumption of total olive oil and its varieties on the risk of osteoporosis-related fractures in a middle-aged and elderly Mediterranean population. METHODS: We included all participants (n = 870) recruited in the Reus (Spain) centre of the PREvención con DIeta MEDiterránea (PREDIMED) trial. Individuals, aged 55-80 years at high cardiovascular risk, were randomized to a MedDiet supplemented with extra-virgin olive oil, a MedDiet supplemented with nuts, or a low-fat diet. The present analysis was an observational cohort study nested in the trial. A validated food frequency questionnaire was used to assess dietary habits and olive oil consumption. Information on total osteoporotic fractures was obtained from a systematic review of medical records. The association between yearly repeated measurements of olive oil consumption and fracture risk was assessed by multivariate Cox proportional hazards. RESULTS: We documented 114 incident cases of osteoporosis-related fractures during a median follow-up of 8.9 years. Treatment allocation had no effect on fracture risk. Participants in the highest tertile of extra-virgin olive oil consumption had a 51% lower risk of fractures (HR:0.49; 95% CI:0.29-0.81. P for trend = 0.004) compared to those in the lowest tertile after adjusting for potential confounders. Total and common olive oil consumption was not associated with fracture risk. CONCLUSIONS: Higher consumption of extra-virgin olive oil is associated with a lower risk of osteoporosis-related fractures in middle-aged and elderly Mediterranean population at high cardiovascular risk.


Assuntos
Azeite de Oliva/uso terapêutico , Fraturas por Osteoporose , Idoso , Dieta Mediterrânea , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Fraturas por Osteoporose/dietoterapia , Fraturas por Osteoporose/epidemiologia , Fraturas por Osteoporose/prevenção & controle
5.
Neurology ; 87(16): 1674-1680, 2016 Oct 18.
Artigo em Inglês | MEDLINE | ID: mdl-27534711

RESUMO

OBJECTIVE: To determine whether calcium supplementation is associated with the development of dementia in women after a 5-year follow-up. METHODS: This was a longitudinal population-based study. The sample was derived from the Prospective Population Study of Women and H70 Birth Cohort Study in Gothenburg, Sweden, and included 700 dementia-free women aged 70-92 years. At baseline in 2000-2001, and at follow-up in 2005-2006, the women underwent comprehensive neuropsychiatric and somatic examinations. A CT scan was performed in 447 participants at baseline. Information on the use and dosage of calcium supplements was collected. Dementia was diagnosed according to DSM-III-R criteria. RESULTS: Women treated with calcium supplements (n = 98) were at a higher risk of developing dementia (odds ratio [OR] 2.10, 95% confidence interval [CI] 1.01-4.37, p = 0.046) and the subtype stroke-related dementia (vascular dementia and mixed dementia) (OR 4.40, 95% CI 1.54-12.61, p = 0.006) than women not given supplementation (n = 602). In stratified analyses, calcium supplementation was associated with the development of dementia in groups with a history of stroke (OR 6.77, 95% CI 1.36-33.75, p = 0.020) or presence of white matter lesions (OR 2.99, 95% CI 1.28-6.96, p = 0.011), but not in groups without these conditions. CONCLUSIONS: Calcium supplementation may increase the risk of developing dementia in elderly women with cerebrovascular disease. Because our sample was relatively small and the study was observational, these findings need to be confirmed.


Assuntos
Cálcio da Dieta/administração & dosagem , Demência/dietoterapia , Suplementos Nutricionais , Idoso , Apolipoproteína E4/genética , Encéfalo/diagnóstico por imagem , Cortisona/administração & dosagem , Demência/complicações , Demência/epidemiologia , Demência/genética , Estrogênios/administração & dosagem , Feminino , Seguimentos , Terapia de Reposição Hormonal , Humanos , Estudos Longitudinais , Fraturas por Osteoporose/complicações , Fraturas por Osteoporose/dietoterapia , Fraturas por Osteoporose/epidemiologia , Fraturas por Osteoporose/genética , Estudos Prospectivos , Risco , Acidente Vascular Cerebral/complicações , Acidente Vascular Cerebral/dietoterapia , Acidente Vascular Cerebral/epidemiologia , Acidente Vascular Cerebral/genética , Suécia , Falha de Tratamento , Vitamina D/administração & dosagem
6.
Arq Bras Endocrinol Metabol ; 58(5): 411-33, 2014 Jul.
Artigo em Inglês, Português | MEDLINE | ID: mdl-25166032

RESUMO

OBJECTIVE: The objective is to present an update on the diagnosis and treatment of hypovitaminosis D, based on the most recent scientific evidence. MATERIALS AND METHODS: The Department of Bone and Mineral Metabolism of the Brazilian Society of Endocrinology and Metabology (SBEM) was invited to generate a document following the rules of the Brazilian Medical Association (AMB) Guidelines Program. Data search was performed using PubMed, Lilacs and SciELO and the evidence was classified in recommendation levels, according to the scientific strength and study type. CONCLUSION: A scientific update regarding hypovitaminosis D was presented to serve as the basis for the diagnosis and treatment of this condition in Brazil.


Assuntos
Calcifediol/sangue , Colecalciferol/uso terapêutico , Ergocalciferóis/uso terapêutico , Deficiência de Vitamina D/diagnóstico , Deficiência de Vitamina D/tratamento farmacológico , Cirurgia Bariátrica/efeitos adversos , Brasil/epidemiologia , Cálcio da Dieta/uso terapêutico , Bases de Dados Bibliográficas , Medicina Baseada em Evidências/normas , Humanos , Hiperparatireoidismo/etiologia , Síndromes de Malabsorção/etiologia , Osteoporose/dietoterapia , Fraturas por Osteoporose/dietoterapia , Hormônio Paratireóideo/sangue , Fatores de Risco , Deficiência de Vitamina D/epidemiologia
7.
Arq. bras. endocrinol. metab ; 58(5): 411-433, 07/2014. tab, graf
Artigo em Português | LILACS | ID: lil-719199

RESUMO

Objetivo Apresentar uma atualização sobre o diagnóstico e tratamento da hipovitaminose D baseada nas mais recentes evidências científicas. Materiais e métodos O Departamento de Metabolismo Ósseo e Mineral da Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) foi convidado a conceber um documento seguindo as normas do Programa Diretrizes da Associação Médica Brasileira (AMB). A busca dos dados foi realizada por meio do PubMed, Lilacs e SciELO e foi feita uma classificação das evidências em níveis de recomendação, de acordo com a força científica por tipo de estudo. Conclusão Foi apresentada uma atualização científica a respeito da hipovitaminose D que servirá de base para o diagnóstico e tratamento dessa condição no Brasil. .


Objective The objective is to present an update on the diagnosis and treatment of hypovitaminosis D, based on the most recent scientific evidence. Materials and methods The Department of Bone and Mineral Metabolism of the Brazilian Society of Endocrinology and Metabology (SBEM) was invited to generate a document following the rules of the Brazilian Medical Association (AMB) Guidelines Program. Data search was performed using PubMed, Lilacs and SciELO and the evidence was classified in recommendation levels, according to the scientific strength and study type. Conclusion A scientific update regarding hypovitaminosis D was presented to serve as the basis for the diagnosis and treatment of this condition in Brazil. .


Assuntos
Humanos , Calcifediol/sangue , Colecalciferol/uso terapêutico , Ergocalciferóis/uso terapêutico , Deficiência de Vitamina D/diagnóstico , Deficiência de Vitamina D/tratamento farmacológico , Cirurgia Bariátrica/efeitos adversos , Brasil/epidemiologia , Cálcio da Dieta/uso terapêutico , Bases de Dados Bibliográficas , Medicina Baseada em Evidências/normas , Hiperparatireoidismo/etiologia , Síndromes de Malabsorção/etiologia , Osteoporose/dietoterapia , Fraturas por Osteoporose/dietoterapia , Hormônio Paratireóideo/sangue , Fatores de Risco , Deficiência de Vitamina D/epidemiologia
8.
Curr Osteoporos Rep ; 10(4): 296-302, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23001895

RESUMO

Diet, a modifiable osteoporosis risk factor, plays an important role in the acquisition and maintenance of bone mass. The influence of diet on bone begins in childhood; even maternal diet can influence bone mass in the offspring. A good general nutritional status and adequate dietary protein, calcium, vitamin D, fruits, and vegetables have a positive influence on bone health, while a high caloric diet and heavy alcohol consumption have been associated with lower bone mass and higher rates of fracture. The evidence for a role of other minerals and vitamins in skeletal health is not as strong, but recent evidence suggests that vitamins C and K might also have an effect on bone.


Assuntos
Osteoporose/dietoterapia , Fraturas por Osteoporose/dietoterapia , Alcoolismo/complicações , Bebidas/efeitos adversos , Densidade Óssea , Cálcio da Dieta , Proteínas na Dieta , Ingestão de Energia , Frutas , Humanos , Minerais , Fatores de Risco , Verduras , Vitamina D
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...